Citation 69185

YANG,XW: MIYASHIRO,H: HATTORI,M: NAMBA,T: TEZUKA,Y: KIKUCHI,T: CHEN,DF: XU,GJ: HORI,T: EXTINE,M: MIZUNO,H:. (1992). ISOLATION OF NOVEL LIGNANS, HETEROCLITINS F AND G, FROM THE STEMS OF KADSURA HETEROCLITA, AND ANTI-LIPID PEROXIDATIVE ACTIONS OF HETEROCLITINS A-G AND RELATED COMPOUNDS IN THE IN VITRO RAT LIVER HOMOGENATE SYSTEM.. 40(6)

Citation Details

Title	ISOLATION OF NOVEL LIGNANS, HETEROCLITINS F AND G, FROM THE STEMS OF KADSURA HETEROCLITA, AND ANTI-LIPID PEROXIDATIVE ACTIONS OF HETEROCLITINS A-G AND RELATED COMPOUNDS IN THE IN VITRO RAT LIVER HOMOGENATE SYSTEM.
Authors	YANG,XW: MIYASHIRO,H: HATTORI,M: NAMBA,T: TEZUKA,Y: KIKUCHI,T: CHEN,DF: XU,GJ: HORI,T: EXTINE,M: MIZUNO,H:
Year	1992
Volume	40
Issue	6

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Kadsura heteroclita (SCHISANDRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	HETEROCLITIN F	None
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN F	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN F	INACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN F	ACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	HETEROCLITIN G	None
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN G	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN G	INACTIVE
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN G	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HETEROCLITIN A	None
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN A	ACTIVE
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN A	WEAK ACTIVITY
12	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN A	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HETEROCLITIN B	None
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN B	ACTIVE
15	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN B	INACTIVE
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN B	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HETEROCLITIN C	None
18	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN C	ACTIVE
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN C	INACTIVE
20	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN C	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	INTERIORIN	None
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INTERIORIN	ACTIVE
23	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INTERIORIN	INACTIVE
24	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INTERIORIN	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HETEROCLITIN D	None
26	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN D	ACTIVE
27	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN D	INACTIVE
28	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN D	ACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HETEROCLITIN E	None
30	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN E	ACTIVE
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN E	INACTIVE
32	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROCLITIN E	ACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OF	SITOSTEROL,BETA:SITOSTEN-3-ONE,BETA:	None

Citation 69185

Citation Details

Summary

Organisms and Their Experiments (1)

Kadsura heteroclita (SCHISANDRACEAE)

Show SPARQL Queries (1)

Query 1